No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs4469327 |
chr6:58285920-58285921 |
Weak transcription Enhancers Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs561005963 |
chr6:58285941-58285942 |
Weak transcription Enhancers Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs547751092 |
chr6:58285957-58285958 |
Weak transcription Enhancers Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs576706835 |
chr6:58285971-58285972 |
Weak transcription Enhancers Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs543985279 |
chr6:58285991-58285992 |
Weak transcription Enhancers Transcr. at gene 5' and 3'
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs565482133 |
chr6:58286018-58286019 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs532659291 |
chr6:58286060-58286061 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs372926570 |
chr6:58286079-58286080 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs548089837 |
chr6:58286099-58286100 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs559474492 |
chr6:58286102-58286103 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs530078924 |
chr6:58286202-58286203 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs548275596 |
chr6:58286216-58286217 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs373916269 |
chr6:58286270-58286271 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs200015816 |
chr6:58286309-58286310 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs369823321 |
chr6:58286313-58286314 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs75174700 |
chr6:58286330-58286331 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs569770533 |
chr6:58286350-58286351 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs181938660 |
chr6:58286356-58286357 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs578077770 |
chr6:58286363-58286364 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs377521562 |
chr6:58286453-58286454 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs111356813 |
chr6:58286484-58286485 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs571443353 |
chr6:58286495-58286496 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs567527670 |
chr6:58286537-58286538 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs186933705 |
chr6:58286540-58286541 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs370764224 |
chr6:58286549-58286550 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs373191115 |
chr6:58286552-58286553 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs565669163 |
chr6:58286559-58286560 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs536299255 |
chr6:58286576-58286577 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs554608073 |
chr6:58286587-58286588 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs71549776 |
chr6:58286627-58286628 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs191352944 |
chr6:58286634-58286635 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs70993114 |
chr6:58286637-58286638 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs181358272 |
chr6:58286727-58286728 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs377469630 |
chr6:58286840-58286841 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs543516577 |
chr6:58286849-58286850 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs558854560 |
chr6:58286857-58286858 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs536348510 |
chr6:58286882-58286883 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs577394573 |
chr6:58286922-58286923 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs541354199 |
chr6:58286924-58286925 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs559668515 |
chr6:58286938-58286939 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs71550553 |
chr6:58286981-58286982 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs377140745 |
chr6:58287019-58287020 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs541783588 |
chr6:58287073-58287074 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs370268613 |
chr6:58287091-58287092 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs563358486 |
chr6:58287124-58287125 |
Weak transcription Active TSS Flanking Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs200381870 |
chr6:58287238-58287239 |
Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs373679395 |
chr6:58287239-58287240 |
Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs146555904 |
chr6:58287243-58287244 |
Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs113766643 |
chr6:58287248-58287249 |
Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs530885708 |
chr6:58287249-58287250 |
Active TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|